Related Experiment Video
Updated: May 21, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Acute pancreatitis induced by methimazole therapy
Albin Abraham1, Pooja Raghavan, Rajshree Patel
1Department of Internal Medicine, Nassau University Medical Center, East Meadow, N.Y.
Abstract:
Among the causative factors for acute pancreatitis, adverse drug reactions are considered to be rare. The diagnosis of drug-induced pancreatitis (DIP) is challenging to establish, and is often underestimated because of the difficulties in determining the causative agent and the need for a retrospective re-evaluation of the suspected agent. We present the case of an 80-year-old woman who presented with complaints of abdominal pain. Her medications included methimazole (MMI) which she had been on for the past 3 months. Computed tomography of her abdomen showed peripancreatic fat stranding with trace amount of surrounding fluid, along with amylase and lipase levels suggestive of acute pancreatitis. In the absence of classical risk factors for acute pancreatitis, a diagnosis of DIP secondary to MMI use was made. Withdrawal of the drug from her medication regimen was accompanied by relief of symptoms and resolution of clinical evidence of pancreatitis. The aim of this paper is to report only the fourth case of MMI-induced pancreatitis in the published literature, and to illustrate the significance of an appropriate and timely diagnosis of DIP.
Insights
Adverse drug reactions causing acute pancreatitis are rare. This case highlights methimazole (MMI) as a potential cause, emphasizing the importance of timely diagnosis for drug-induced pancreatitis (DIP).
Area of Science:
- Endocrinology
- Gastroenterology
- Pharmacology
Background:
- Adverse drug reactions (ADRs) are an uncommon cause of acute pancreatitis.
- Diagnosing drug-induced pancreatitis (DIP) is challenging due to difficulties in identifying the causative agent and requires retrospective analysis.
Observation:
- An 80-year-old woman presented with abdominal pain and was found to have acute pancreatitis.
- Her medication history included methimazole (MMI), an antithyroid drug, used for three months.
- Abdominal CT revealed peripancreatic fat stranding and fluid, with elevated amylase and lipase levels.
Findings:
- In the absence of other risk factors, DIP secondary to methimazole (MMI) was diagnosed.
- Discontinuation of MMI led to symptom resolution and clinical recovery from pancreatitis.
- This represents the fourth reported case of MMI-induced pancreatitis in medical literature.
Implications:
- This case underscores the importance of considering drug-induced pancreatitis (DIP) in patients presenting with acute pancreatitis, especially when other risk factors are absent.
- Clinicians should maintain a high index of suspicion for methimazole (MMI) as a potential causative agent for DIP.
- Prompt diagnosis and withdrawal of the offending drug are crucial for managing drug-induced pancreatitis (DIP) and improving patient outcomes.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
14:39A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
Published on: January 9, 2026
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Pathophysiology